Neurological Manifestations as a Harbinger of Myocarditis in Patients Treated With Immune Checkpoint Inhibitors

Affiliation

• ¹ Simone Rossi, MD, and Ilaria Cani, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy, Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum-University of Bologna, Bologna, Italy; Emanuel Raschi, MD, PhD, Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy; Francesca Comito, MD, PhD, Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum-University of Bologna, Bologna, Italy; Rita Rinaldi, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Andrea Ardizzoni, MD, Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum-University of Bologna, Bologna, Italy; Maria Guarino, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; and Francesco Gelsomino, MD, Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Alma Mater Studiorum-University of Bologna, Bologna, Italy.